Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $24.88 USD
Change Today -0.27 / -1.07%
Volume 785.6K
QGEN On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Metin Colpan Ph.D.

Co-Founder, Supervisory Director and Chairman of Science & Technology Committee, Qiagen NV
AgeTotal Calculated CompensationThis person is connected to 10 board members in 2 different organizations across 4 different industries.

See Board Relationships
60$63,500

Background*

Dr. Metin Colpan, Ph.D. served as Senior Technology Advisor of Qiagen NV. Dr. Colpan serves as an Active Consultant for the federal and state governments of Germany. Dr. Colpan Co-founded Qiagen NV and served as its Chief Executive Officer and President from 1985 to 2003. Dr. Colpan served as the Managing Director of Qiagen NV from 1985 to 2003, where he successfully led Qiagen NV to its position as one of the leading global life sciences companies. Prior to Co-founding ...

Read Full Background

Corporate Headquarters*

Spoorstraat 50
Venlo, Limburg 5911 KJ

Netherlands

Phone: 31 77 320 8400
Fax: 31 77 320 8409

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MS 1983
Technische Universität Darmstadt
PhD 1983
Technische Universität Darmstadt

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options29,314
Unexercisable Options521
Total Number of Options29,835

Total Compensation*

Total Annual Cash Compensation$63,500
Total Calculated Compensation$63,500
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
QGEN:US $24.88 USD -0.27

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John L. Bishop Chairman, Chief Executive Officer and Member of Equity Incentive Committee
Cepheid
$664.9K
Mark Christopher Capone Chief Executive Officer and President
Myriad Genetics Inc.
$568.0K
Norman D. Schwartz Chairman, Chief Executive Officer and President
Bio-Rad Laboratories, Inc.
$843.1K
Robert F. Friel Chairman, Chief Executive Officer, President and Member of Finance Committee
PerkinElmer Inc.
$1.0M
Alexandre Merieux Chief Executive Officer, Director and Member of Strategy Committee
bioMérieux SA
€669.5K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact QIAGEN N.V., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.